Japan’s Takeda provides exit for European PE firm
Takeda Pharmaceutical Co, one of the largest pharmaceutical companies in Japan has reportedly planned to take over Zurich-headquartered pharmaceutical maker Nycomed, which is owned by European private equity firm Nordic Capital and Credit Suisse’s private-equity unit.
A report on Bloomberg suggested that the deal could be worth at around $14.2 billion if it materializes. The article further noted that negotiation between the two parties is in an advanced stake and a...
More on Healthcare
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.